Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT05239858

International Wilson’s Disease Patient Registry (iWilson Registry)

International Wilson’s Disease Patient Registry (iWilson Registry) — Recruiting • Gastroenterology • NCT05239858.

📅 11 Aug 2026 ⏱ 1 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT05239858
Sponsor
Orphalan
Start
2022-06-29
ClinicaliQ Trial Snapshot
  • International Wilson’s Disease Patient Registry (iWilson Registry) — Recruiting • Gastroenterology • NCT05239858.
  • What is being tested: The iWilson Registry is a longitudinal, observational study collecting standardised clinical data from Wilson's disease patients attending routine clinic visits over 6-12 month intervals, supplemented by retrospective historical data at enrolment, without any investigational interventions.
  • Patient eligibility overview: The registry enrolls Wilson's disease patients attending participating WD specialist clinics who consent to data collection during their standard-of-care appointments; specific inclusion/exclusion criteria determine individual patient participation.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Longitudinal, observational, non-interventional, standard of care Registry. Data will be collected from the routinely scheduled WD clinic visits at approximately 6-12 month intervals. At enrolment, in addition to data from the clinic visit, retrospective data will be collected from the diagnostic evaluation and any relevant past medical history and a summary of WD medication history.

Eligibility Snapshot
  • :
  • Patient is able to provide, and has provided, written informed consent/assent 2. Written documentation has been obtained in accordance with the relevant country and local privacy requirements, where applicable, including: 1. For US sites: Authorization for Use and Release of Health Research Study Information 2. For EU sites: Data Protection Consent 3. All patients diagnosed with WD including pre-symptomatic individuals and individuals with co-morbidities/diagnoses 4. Any treatments including prescribed and homeopathic/traditional therapies or naive patients on no therapy

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Guideline
Cirrhosis in Over 16s: Assessment and Management (NICE NG50)
Gastroenterology · 27 Mar 2026
Perform upper endoscopy to screen all cirrhosis patients for oesophageal varices; if present, offer variceal band ligation and initiate non-selective beta-blockers (propranolol…
View guideline →
Guideline
2023 EASL-EASD-EASO Clinical Practice Guidelines for MASLD
Gastroenterology · 30 Mar 2026
This EASL guideline addresses 2023 EASL-EASD-EASO Clinical Practice Guidelines for MASLD in Gastroenterology. Use it to review current recommendation wording, eligibility criteria,…
View guideline →
Guideline
Hepatitis B (Chronic): Diagnosis and Management (NICE NG133)
Gastroenterology · 27 Mar 2026
Assess all newly diagnosed chronic hepatitis B patients with HBsAg, anti-HBc, HBeAg, anti-HBe, quantitative HBV DNA, ALT, and liver function tests before…
View guideline →
Clinical Brief
UKHSA and Stablepharma highlight breakthrough with fridge-free tetanus and diphtheria vaccine
Gastroenterology · UKHSA · 13 Mar 2026
Stablepharma has developed a thermostable tetanus and diphtheria vaccine requiring no cold-chain storage, addressing a critical logistical barrier to immunisation in resource-limited…
View brief →
Guideline
Ex-situ machine perfusion devices to preserve deceased donor livers for transplantation
Gastroenterology · 20 Aug 2026
Consider ex-situ machine perfusion as an alternative to static cold storage for deceased donor livers, particularly for higher-risk grafts (extended criteria donors,…
View guideline →
Clinical Brief
Islanders’ lifestyle views could help shape future
Gastroenterology · BBC Health · 14 Jun 2026
Island populations demonstrate distinct lifestyle patterns and health behaviours that warrant consideration in service planning, with potential applicability to broader UK healthcare…
View brief →